S&P 500   3,324.30 (+0.23%)
DOW   29,348.16 (+0.17%)
QQQ   222.71 (+0.19%)
AAPL   316.41 (+0.37%)
FB   221.58 (-0.09%)
MSFT   166.34 (+0.10%)
AMZN   1,871.48 (-0.34%)
NVDA   248.86 (-0.03%)
BABA   226.39 (+1.09%)
MU   57.49 (-0.35%)
TSLA   512.77 (-0.14%)
AMD   50.41 (+1.27%)
T   38.16 (+0.32%)
ACB   2.14 (-0.93%)
F   9.19 (+0.22%)
NFLX   340.54 (+0.57%)
BAC   34.81 (+0.26%)
GILD   62.76 (-0.70%)
DIS   145.08 (-0.03%)
S&P 500   3,324.30 (+0.23%)
DOW   29,348.16 (+0.17%)
QQQ   222.71 (+0.19%)
AAPL   316.41 (+0.37%)
FB   221.58 (-0.09%)
MSFT   166.34 (+0.10%)
AMZN   1,871.48 (-0.34%)
NVDA   248.86 (-0.03%)
BABA   226.39 (+1.09%)
MU   57.49 (-0.35%)
TSLA   512.77 (-0.14%)
AMD   50.41 (+1.27%)
T   38.16 (+0.32%)
ACB   2.14 (-0.93%)
F   9.19 (+0.22%)
NFLX   340.54 (+0.57%)
BAC   34.81 (+0.26%)
GILD   62.76 (-0.70%)
DIS   145.08 (-0.03%)
S&P 500   3,324.30 (+0.23%)
DOW   29,348.16 (+0.17%)
QQQ   222.71 (+0.19%)
AAPL   316.41 (+0.37%)
FB   221.58 (-0.09%)
MSFT   166.34 (+0.10%)
AMZN   1,871.48 (-0.34%)
NVDA   248.86 (-0.03%)
BABA   226.39 (+1.09%)
MU   57.49 (-0.35%)
TSLA   512.77 (-0.14%)
AMD   50.41 (+1.27%)
T   38.16 (+0.32%)
ACB   2.14 (-0.93%)
F   9.19 (+0.22%)
NFLX   340.54 (+0.57%)
BAC   34.81 (+0.26%)
GILD   62.76 (-0.70%)
DIS   145.08 (-0.03%)
S&P 500   3,324.30 (+0.23%)
DOW   29,348.16 (+0.17%)
QQQ   222.71 (+0.19%)
AAPL   316.41 (+0.37%)
FB   221.58 (-0.09%)
MSFT   166.34 (+0.10%)
AMZN   1,871.48 (-0.34%)
NVDA   248.86 (-0.03%)
BABA   226.39 (+1.09%)
MU   57.49 (-0.35%)
TSLA   512.77 (-0.14%)
AMD   50.41 (+1.27%)
T   38.16 (+0.32%)
ACB   2.14 (-0.93%)
F   9.19 (+0.22%)
NFLX   340.54 (+0.57%)
BAC   34.81 (+0.26%)
GILD   62.76 (-0.70%)
DIS   145.08 (-0.03%)
Log in

NYSE:CHE - Chemed Stock Price, Forecast & News

$472.01
-1.24 (-0.26 %)
(As of 01/17/2020 10:38 AM ET)
Today's Range
$472.01
Now: $472.01
$474.69
50-Day Range
$424.76
MA: $440.97
$473.25
52-Week Range
$282.11
Now: $472.01
$474.51
Volume137 shs
Average Volume66,700 shs
Market Capitalization$7.56 billion
P/E Ratio39.56
Dividend Yield0.27%
Beta1.09
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations. Read More…

Industry, Sector and Symbol

Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
CUSIP16359R10
Phone513-762-6690

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.78 billion
Cash Flow$15.23 per share
Book Value$36.93 per share

Profitability

Net Income$205.54 million

Miscellaneous

Employees15,707
Market Cap$7.56 billion
Next Earnings Date2/19/2020 (Estimated)
OptionableOptionable

Receive CHE News and Ratings via Email

Sign-up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.


Chemed (NYSE:CHE) Frequently Asked Questions

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed announced a quarterly dividend on Friday, November 1st. Stockholders of record on Monday, November 11th will be paid a dividend of $0.32 per share on Monday, December 2nd. This represents a $1.28 annualized dividend and a dividend yield of 0.27%. The ex-dividend date of this dividend is Thursday, November 7th. View Chemed's Dividend History.

How will Chemed's stock buyback program work?

Chemed declared that its board has approved a share repurchase plan on Wednesday, March 7th 2018, which allows the company to repurchase $150,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Shares repurchase plans are typically a sign that the company's leadership believes its stock is undervalued.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) posted its quarterly earnings results on Tuesday, October, 29th. The company reported $3.46 EPS for the quarter, topping analysts' consensus estimates of $3.31 by $0.15. The firm earned $480.61 million during the quarter, compared to analysts' expectations of $478.89 million. Chemed had a net margin of 11.14% and a return on equity of 35.06%. Chemed's revenue was up 8.2% compared to the same quarter last year. During the same period last year, the company posted $3.07 earnings per share. View Chemed's Earnings History.

When is Chemed's next earnings date?

Chemed is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Chemed.

What price target have analysts set for CHE?

4 equities research analysts have issued 1-year price objectives for Chemed's shares. Their forecasts range from $405.00 to $500.00. On average, they anticipate Chemed's stock price to reach $466.25 in the next year. This suggests that the stock has a possible downside of 1.2%. View Analyst Price Targets for Chemed.

What is the consensus analysts' recommendation for Chemed?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemed.

Has Chemed been receiving favorable news coverage?

Headlines about CHE stock have trended positive on Friday, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Chemed earned a daily sentiment score of 3.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for Chemed.

Are investors shorting Chemed?

Chemed saw a drop in short interest in December. As of December 13th, there was short interest totalling 211,300 shares, a drop of 18.0% from the November 28th total of 257,700 shares. Based on an average daily volume of 89,500 shares, the days-to-cover ratio is currently 2.4 days. Approximately 1.4% of the shares of the stock are sold short. View Chemed's Current Options Chain.

Who are some of Chemed's key competitors?

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include Home Depot (HD), CVS Health (CVS), Chevron (CVX), Walt Disney (DIS), Altria Group (MO), Boeing (BA), BlackRock (BLK), AT&T (T), UnitedHealth Group (UNH) and Comcast (CMCSA).

Who are Chemed's key executives?

Chemed's management team includes the folowing people:
  • Mr. Kevin J. McNamara, CEO, Pres & Director (Age 65)
  • Mr. David P. Williams, Exec. VP & CFO (Age 58)
  • Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 65)
  • Mr. Spencer S. Lee, Exec. VP (Age 63)
  • Mr. Nicholas Michael Westfall, Exec. VP (Age 40)

Who are Chemed's major shareholders?

Chemed's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (2.29%), Boston Trust Walden Corp (0.75%), Hanson & Doremus Investment Management (0.03%), TrimTabs Asset Management LLC (0.02%), State of Alaska Department of Revenue (0.02%) and AE Wealth Management LLC (0.01%). Company insiders that own Chemed stock include David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee, Thomas P Rice and Walter L Krebs. View Institutional Ownership Trends for Chemed.

Which institutional investors are selling Chemed stock?

CHE stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, State of Alaska Department of Revenue, Hanson & Doremus Investment Management, TrimTabs Asset Management LLC, IFP Advisors Inc and We Are One Seven LLC. Company insiders that have sold Chemed company stock in the last year include David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Spencer S Lee, Thomas P Rice and Walter L Krebs. View Insider Buying and Selling for Chemed.

Which institutional investors are buying Chemed stock?

CHE stock was acquired by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp, AE Wealth Management LLC, Calamos Advisors LLC, Private Trust Co. NA, First Hawaiian Bank and Delta Capital Management LLC. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.

How do I buy shares of Chemed?

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $472.01.

How big of a company is Chemed?

Chemed has a market capitalization of $7.56 billion and generates $1.78 billion in revenue each year. The company earns $205.54 million in net income (profit) each year or $11.93 on an earnings per share basis. Chemed employs 15,707 workers across the globe.View Additional Information About Chemed.

What is Chemed's official website?

The official website for Chemed is http://www.chemed.com/.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.


MarketBeat Community Rating for Chemed (NYSE CHE)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  273 (Vote Outperform)
Underperform Votes:  342 (Vote Underperform)
Total Votes:  615
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe CHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2020 by MarketBeat.com Staff

Featured Article: What is Forex?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel